FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:911-913 September 16, 1999 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Recent data indicate that an estimated 2.7 million people in the United States are chronically infected with hepatitis C virus (HCV).¹ Hepatitis C has become the most common reason for liver transplantation and has been called the silent epidemic in numerous articles in the news media. Transfusion-associated HCV infection has become rare since blood-donor screening was initiated in 1990; the risk has decreased from 0.45 percent to 0.001 percent per unit of blood transfused.² Nonetheless, many people were infected through transfusion, and some were infants or young children at the time of infection. In the United States, testing for HCV . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.